Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

INDUSTRY 8OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 8Dermatologic 7Other hematologic neoplasm 4Gynecologic 4CNS 4Thoracic 3Plasma cell 3Breast 3Sarcoma 2Myeloid 2Lymphoid 2Gastrointestinal 2Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Lung Neoplasms 1

Interventions

Carboplatin 510Cisplatin 410Pemetrexed 400Radiotherapy 285Docetaxel 244Paclitaxel 227pembrolizumab 226Gemcitabine 198Drug Therapy 191Bevacizumab 190Erlotinib Hydrochloride 189Radiosurgery 177Nivolumab 168Etoposide 155durvalumab 154osimertinib 126atezolizumab 109Gefitinib 96Blood Specimen Collection 93Magnetic Resonance Spectroscopy 91Vinorelbine 90anlotinib 88Surgical Procedures, Operative 85Ipilimumab 62Immunotherapy 62Surveys and Questionnaires 60sintilimab 59Specimen Handling 59tislelizumab 58Irinotecan 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Itraconazole × Thoracic × Clear all
NCT02357836 2021-05-03

Neoadjuvant Itraconazole in Non-small Cell Lung Cancer

University of Texas Southwestern Medical Center

Phase EARLY_PHASE1 Completed
13 enrolled 12 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00769600 2019-02-01

Phase II Study of Itraconazole and Pemetrexed in Patients With Previously Treated Non-Squamous NSCLC

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated
23 enrolled 11 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03664115 2018-09-10

Itraconazole in Non Small Cell Lung Cancer

Ain Shams University

Phase 2 Unknown
60 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡